Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.57
-0.5514-1.96%
Volume:11.38M
Turnover:316.86M
Market Cap:156.75B
PE:36.28
High:28.15
Open:28.10
Low:27.55
Close:28.12
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.93
T/O Rate:0.20%
Dividend:1.72
Dividend Rate:6.24%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.84
PE(LYR):20.21

Loading ...

Pfizer Expands Autoimmune Pipeline With New Early-Stage Trial of PF-08154225

TIPRANKS
·
Aug 29

Pfizer Targets China’s Obesity Market With New Phase 3 Berobenatide Trial

TIPRANKS
·
Aug 29

NYSE Most Active Issues

Dow Jones
·
Aug 28

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Dow Jones
·
Aug 28

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

TIPRANKS
·
Aug 28

Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults

Reuters
·
Aug 28

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately

THOMSON REUTERS
·
Aug 28

Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance

THOMSON REUTERS
·
Aug 28

Pfizer’s Korean Vyndamax Study Update: What It Means for ATTR-CM Investors

TIPRANKS
·
Aug 28

China's Drug Regulator Accepts Novo Nordisk's Application for Oral Wegovy

Reuters
·
Aug 27

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Pfizer Stock (PFE) Is a Buy despite Declining Revenues

TIPRANKS
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Pfizer Shows Signs of Stabilization as New Drug Revenue Surges 18%, Yet Patent Expirations Remain the Ultimate Hurdle

Stock News
·
Aug 24

Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

TIPRANKS
·
Aug 22

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case (PFE)?

Simply Wall St.
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Pfizer’s India Migraine Study Adds Real-World Momentum for PFE

TIPRANKS
·
Aug 22

Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies

TIPRANKS
·
Aug 22

Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

TIPRANKS
·
Aug 22